Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoying Shang

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Cancer Discovery|May 10, 2020
Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate CancerDi Zhao, Li Cai, Xin Lu, et al.
Nature|June 21, 2023
Histone demethylase KDM5D upregulation drives sex differences in colon cancerJiexi Li, Zhengdao Lan, Wenting Liao, et al.
Cancer Discovery|February 13, 2020
Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor MicroenvironmentPrasenjit Dey, Jun Li, Jianhua Zhang, et al.
Nature Cancer|December 30, 2022
Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancerPat Gulhati, Aislyn Schalck, Shan Jiang, et al.
Cancer Cell|March 26, 2019
KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal CancerWenting Liao, Michael J Overman, Adam T Boutin, et al.
Cancer Discovery|December 25, 2015
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor ProgressionGuocan Wang, Xin Lu, Prasenjit Dey, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Cancer Discovery|May 10, 2020
Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate CancerDi Zhao, Li Cai, Xin Lu, et al.
Nature|June 21, 2023
Histone demethylase KDM5D upregulation drives sex differences in colon cancerJiexi Li, Zhengdao Lan, Wenting Liao, et al.
Cancer Discovery|February 13, 2020
Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor MicroenvironmentPrasenjit Dey, Jun Li, Jianhua Zhang, et al.
Nature Cancer|December 30, 2022
Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancerPat Gulhati, Aislyn Schalck, Shan Jiang, et al.
Cancer Cell|March 26, 2019
KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal CancerWenting Liao, Michael J Overman, Adam T Boutin, et al.
Cancer Discovery|December 25, 2015
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor ProgressionGuocan Wang, Xin Lu, Prasenjit Dey, et al.
Pageof 6